(Q40149924)

17 September 2017

title

Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent (English)

1 reference

17 September 2017

Saima Aslam

1

1 reference

17 September 2017

Daniel M Musher

series ordinal

2

1 reference

17 September 2017

publication date

1 December 2007

1 reference

17 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

583-590

1 reference

Nitazoxanide: a new thiazolide antiparasitic agent

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Pre-clinical toxicology of nitazoxanide--a new antiparasitic compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

Effect of Nitazoxanide in Persistent Diarrhea and Enteritis Associated With

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.6.583

21 January 2018

Identifiers

DOI

10.2217/17460913.2.6.583

1 reference

17 September 2017

1 reference